Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Neural and Metabolic Dysregulation in PMM2 deficient human in vitro neural models

ABSTRACT: Neural and Metabolic Dysregulation in PMM2 deficient human in vitro neural models

PROVIDER: PRJNA1055666 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR27321613_1.fastq.gz	Fastqsanger.gz
	SRR27321613_2.fastq.gz	Fastqsanger.gz
	SRR27321614_1.fastq.gz	Fastqsanger.gz
	SRR27321614_2.fastq.gz	Fastqsanger.gz
	SRR27321615_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 36

Similar Datasets

Neural and Metabolic Dysregulation in PMM2 deficient human in vitro neural models

Project description:PMM2-CDG is a rare inborn error of metabolism caused by deficiency of the phosphomannomutase (PMM2) enzyme, which leads to impaired protein glycosylation. While the disorder presents primarily with neurological symptoms, there is limited knowledge about the specific brain-related changes that result from PMM deficiency. We found aberrant neural activity in 2D neuronal networks from individuals with PMM2-CDG. Multi-omics datasets from 3D brain organoids derived from individuals with PMM2-CDG revealed widespread decrease in protein glycosylation, highlighting impaired glycosylation as a key pathological feature of PMM2-CDG. Further, we identified impaired mitochondrial structure and abnormal glucose metabolism in PMM2-CDG organoids indicating disturbances in energy metabolism. Correlation between PMM2 enzymatic activity in brain organoids and symptom severity suggests that the level of PMM2 enzyme function directly influences neurological manifestations. These findings enhance our understanding of specific brain-related perturbations associated with PMM2-CDG, offering insights into the underlying mechanisms and potential directions for therapeutic interventions.

2024-04-25 | PXD044647 | Pride

Neural and Metabolic Dysregulation in PMM2 deficient human in vitro neural models

Project description:PMM2-CDG is a rare inborn error of metabolism caused by deficiency of the phosphomannomutase-2 (PMM2) enzyme, which leads to impaired protein glycosylation. While the disorder presents with primarily neurological symptoms, there is limited knowledge about the specific brain-related changes that result from PMM2 deficiency. We found aberrant neural activity in 2D neuronal networks from individuals with PMM2-CDG. Utilizing multi-omics datasets from 3D brain organoids derived from individuals with PMM2-CDG, we found widespread decreases in protein glycosylation, highlighting impaired glycosylation as a key pathological feature of PMM2-CDG. Furthermore, we identified impaired mitochondrial structure and abnormal glucose metabolism in PMM2-CDG brain organoids, indicating disturbances in energy metabolism. Correlation between PMM2 enzymatic activity in brain organoids and symptom severity suggests that the level of PMM2 enzyme function directly influences neurological manifestations. These findings enhance our understanding of specific brain-related perturbations associated with PMM2-CDG, offering insights into the underlying mechanisms and potential directions for therapeutic interventions.

2024-03-12 | GSE251886 | GEO

REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease

Project description:REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease

| PRJNA482597 | ENA

REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (Affymetrix NPC data set)

Project description:REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (Affymetrix NPC data set)

| PRJNA482603 | ENA

REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (Affymetrix iPSC data set)

Project description:REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (Affymetrix iPSC data set)

| PRJNA482599 | ENA

REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (Affymetrix neurons data set)

Project description:REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (Affymetrix neurons data set)

| PRJNA482600 | ENA

REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set)

Project description:REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set)

| PRJNA482601 | ENA

Neuronal Activity-Dependent Gene Dysregulation inC9orf72i3Neuronal Models of ALS/FTD Pathogenesis

Project description:Neuronal Activity-Dependent Gene Dysregulation inC9orf72i3Neuronal Models of ALS/FTD Pathogenesis

| PRJNA1152951 | ENA

Transcriptional dysregulation impairs efficacy of neural stem cell activation during aging.

Project description:Transcriptional dysregulation impairs efficacy of neural stem cell activation during aging.

| PRJNA928369 | ENA

Unraveling autophagic imbalances and therapeutic insights in Mecp2-deficient models

Project description:Unraveling autophagic imbalances and therapeutic insights in Mecp2-deficient models

| PRJNA1133812 | ENA

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data